This article is intended for adult readers located in the United States
The rise of GLP-1 most notably semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)has fundamentally shifted the landscape of weight management.[1] While originally designed for Type 2 diabetes, their ability in inducing weight loss has attracted a new demographic: the overweight athlete
Once blood sugar normalizes, eat a small snack or meal to prevent recurrence
Following the recommended dosing schedule helps minimize these effects
Your provider should monitor nutrient levels through regular blood work, especially during the first months of semaglutide use
Administered subcutaneously, it fits seamlessly into daily routines, requiring just a single injection per week